WIL Research Europe B.V. - Development of a balanced dual PI3K/mTOR kinase inhibitor: A new generation of potential drugs for targeted cancer therapy
The project aims to develop a new generation of targeted cancer therapeutics. PIQUR has identified a novel, innovative, dual PI3K/mTOR inhibitor comparing favourably with the most...